These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1076 related articles for article (PubMed ID: 31639005)
1. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929 [TBL] [Abstract][Full Text] [Related]
3. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923 [TBL] [Abstract][Full Text] [Related]
4. Folic acid attenuates high-fat diet-induced steatohepatitis Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787 [TBL] [Abstract][Full Text] [Related]
5. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis. Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645 [TBL] [Abstract][Full Text] [Related]
6. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Zhang J; Du H; Shen M; Zhao Z; Ye X J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease. Jiang M; Li C; Liu Q; Wang A; Lei M Front Endocrinol (Lausanne); 2019; 10():665. PubMed ID: 31616384 [TBL] [Abstract][Full Text] [Related]
8. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437 [TBL] [Abstract][Full Text] [Related]
9. Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice. Ohashi T; Nakade Y; Ibusuki M; Kitano R; Yamauchi T; Kimoto S; Inoue T; Kobayashi Y; Sumida Y; Ito K; Nakao H; Umezawa K; Yoneda M PLoS One; 2019; 14(1):e0210068. PubMed ID: 30689650 [TBL] [Abstract][Full Text] [Related]
10. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III. Liu C; Guo Q; Lu M; Li Y Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856 [TBL] [Abstract][Full Text] [Related]
11. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411 [TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway. Yang Y; Qiu W; Xiao J; Sun J; Ren X; Jiang L J Transl Med; 2024 Mar; 22(1):309. PubMed ID: 38532480 [TBL] [Abstract][Full Text] [Related]
13. The effect of high-fat diet and inhibition of ceramide production on insulin action in liver. Zabielski P; Daniluk J; Hady HR; Markowski AR; Imierska M; Górski J; Blachnio-Zabielska AU J Cell Physiol; 2019 Feb; 234(2):1851-1861. PubMed ID: 30067865 [TBL] [Abstract][Full Text] [Related]
15. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway. Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668 [TBL] [Abstract][Full Text] [Related]
16. Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats. Yue F; Xia K; Wei L; Xing L; Wu S; Shi Y; Lam SM; Shui G; Xiang X; Russell R; Zhang D J Gastroenterol Hepatol; 2020 Nov; 35(11):1978-1989. PubMed ID: 32027419 [TBL] [Abstract][Full Text] [Related]
17. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis. Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897 [TBL] [Abstract][Full Text] [Related]
20. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]